Institute of Medical Microbiology, University Hospital Münster, Münster, Germany.
DRK Kliniken Berlin, Institute of Hygiene, Berlin, Germany.
BMC Infect Dis. 2021 Feb 16;21(1):181. doi: 10.1186/s12879-021-05885-3.
Numerous multiplex-PCR assays are now available in routine diagnostics but their clinical value is controversial if a clear association between clinical symptoms and the detection of a particular pathogen is missing. The objective of this work was to evaluate a multiplex-PCR assay for the diagnosis of traveller's diarrhoea (TD) in a case-control study and to assess the concordance with the BioFire® FilmArray® Gastrointestinal Panel.
Stool samples from cases (n = 61) and controls (n = 30) were collected during travel and analysed by the GI-EB Screening assay (Seegene) in a case-control study. The concordance with the BioFire® FilmArray® Gastrointestinal Panel was expressed as the proportion of participants in which both tests agreed in the category "detected" and "not detected".
None of the test-target organisms (Campylobacter spp., Clostridioides difficile toxin A/B, Salmonella spp., Shigella spp./enteroinvasive Escherichia coli, E. coli O157, Shiga toxin-producing E. coli, Yersinia enterocolitica) was significantly associated with TD GI-EB Screening assay. The GI-EB Screening assay had an agreement with the BioFire® FilmArray® of 86.8-100%.
The selection of test-target organisms included in the GI-EB Screening assay appears inappropriate for the diagnostic work-up of TD as none of the detected pathogens was associated with TD. The GI-EB Screening assay had a good concordance with BioFire® FilmArray®.
目前有许多多重 PCR 检测方法可用于常规诊断,但如果缺乏临床症状与特定病原体检测之间的明确关联,其临床价值仍存在争议。本研究旨在通过病例对照研究评估一种用于旅行者腹泻(TD)诊断的多重 PCR 检测方法,并评估其与 BioFire® FilmArray® 胃肠道Panel 的一致性。
在旅行期间收集病例(n=61)和对照(n=30)的粪便样本,并通过 GI-EB 筛查检测(Seegene)进行分析。用两种检测方法在“检测”和“未检测”类别中均一致的参与者比例来表示与 BioFire® FilmArray® 胃肠道 Panel 的一致性。
测试目标生物体(弯曲菌属、艰难梭菌毒素 A/B、沙门氏菌属、志贺氏菌属/侵袭性大肠埃希菌、E. coli O157、产志贺毒素大肠埃希菌、耶尔森氏菌 enterocolitica)均与 TD GI-EB 筛查检测无显著关联。GI-EB 筛查检测与 BioFire® FilmArray® 的一致性为 86.8-100%。
GI-EB 筛查检测中包含的测试目标生物体的选择似乎不适合 TD 的诊断工作,因为未检测到的病原体均与 TD 无关。GI-EB 筛查检测与 BioFire® FilmArray® 具有良好的一致性。